August 14, 2024
Tag:
ChemExpress leads the field for ADC drug development providing one-stop CRO & CDMO services for both small molecules and ADC conjugation.
ChemExpress have a substantial inventory of over 80 payloads and 400 linkers, in addition to extensive expertise in linker compound synthesis, with over 1,000 successful syntheses.
To date, ChemExpress have empowered over 800 clients to develop their ADC projects. We have collaborated with RemeGen to assist in the development and launching of RC48—the first ADC drug developed and approved in China.
As of August 2024, ChemExpress have 12 ADC related products with DMF. Our clients can directly cite the specific DMF code, thereby expediting the drug review process.
ChemExpress ADC CDMO Services
ChemExpress DMF-Filed ADC Products
MMAE Series
MMAE & Intermediates
Exatecan Series
Exatecan & Intermediates
Eribulin Series
Eribulin Intermediates
Trabectedin Series
Trabectedin Intermediates
Click to learn more about our ADC products
MMAE; Exatecan; Eribulin; PNU-159682; PBD;
Amanitin; Tubulysin; Duocarmycin; STING Agonist, etc.
Ac-{Gly(N-me)}-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar-Sar;
Mc-Val-Ala-PAB-PNP;
DBCO-acid;
MAC qlucuronide linker-2;
Mc-Val-Cit-PABC-PNP;
Lys(MMT)-PAB-oxydiacetamide-PEG8-N3;
Fmoc-Val-Cit-PAB-PNP, etc.
Helpful Resources
ChemExpress ADC Small Molecule Product Handbook>>
ChemExpress ADC CDMO Services Brochure>>
Upcoming Events
CPHI Korea 2024
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: